These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 30766956)

  • 1. Combatting Fibrosis: Exosome-Based Therapies in the Regression of Liver Fibrosis.
    Chen L; Brenner DA; Kisseleva T
    Hepatol Commun; 2019 Feb; 3(2):180-192. PubMed ID: 30766956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver fibrosis: Direct antifibrotic agents and targeted therapies.
    Schuppan D; Ashfaq-Khan M; Yang AT; Kim YO
    Matrix Biol; 2018 Aug; 68-69():435-451. PubMed ID: 29656147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies.
    Xu J; Liu X; Koyama Y; Wang P; Lan T; Kim IG; Kim IH; Ma HY; Kisseleva T
    Front Pharmacol; 2014; 5():167. PubMed ID: 25100997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Hsu WH; Liao SC; Chyan YJ; Huang KW; Hsu SL; Chen YC; Siu ML; Chang CC; Chung YS; Huang CF
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy.
    Li D; Friedman SL
    J Gastroenterol Hepatol; 1999 Jul; 14(7):618-33. PubMed ID: 10440206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis.
    Mallat A; Lotersztajn S
    Am J Physiol Cell Physiol; 2013 Oct; 305(8):C789-99. PubMed ID: 23903700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells.
    Devhare PB; Sasaki R; Shrivastava S; Di Bisceglie AM; Ray R; Ray RB
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the effect of exosomes from different cells on liver fibrosis.
    Hu X; Ge Q; Zhang Y; Li B; Cheng E; Wang Y; Huang Y
    Biomed Pharmacother; 2023 May; 161():114415. PubMed ID: 36812711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of serum extracellular vesicles in liver fibrosis.
    Chen L; Chen R; Kemper S; Cong M; You H; Brigstock DR
    J Extracell Vesicles; 2018; 7(1):1461505. PubMed ID: 29696080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathobiology of liver fibrosis: a translational success story.
    Lee YA; Wallace MC; Friedman SL
    Gut; 2015 May; 64(5):830-41. PubMed ID: 25681399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis.
    Karin D; Koyama Y; Brenner D; Kisseleva T
    Differentiation; 2016 Sep; 92(3):84-92. PubMed ID: 27591095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.
    Elpek GÖ
    World J Gastroenterol; 2014 Jun; 20(23):7260-76. PubMed ID: 24966597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulation of energy metabolism promotes antifibrotic effects in human hepatic stellate cells and prevents liver fibrosis in a mouse model.
    Karthikeyan S; Potter JJ; Geschwind JF; Sur S; Hamilton JP; Vogelstein B; Kinzler KW; Mezey E; Ganapathy-Kanniappan S
    Biochem Biophys Res Commun; 2016 Jan; 469(3):463-9. PubMed ID: 26525850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of fibrosis progression and regression in NASH.
    Schuppan D; Surabattula R; Wang XY
    J Hepatol; 2018 Feb; 68(2):238-250. PubMed ID: 29154966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis.
    Iwaisako K; Brenner DA; Kisseleva T
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):65-8. PubMed ID: 22320919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver fibrosis: a dynamic and potentially reversible process.
    Povero D; Busletta C; Novo E; di Bonzo LV; Cannito S; Paternostro C; Parola M
    Histol Histopathol; 2010 Aug; 25(8):1075-91. PubMed ID: 20552556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes in liver fibrosis: The role of modulating hepatic stellate cells and immune cells, and prospects for clinical applications.
    Liu Y; Zheng Y; Yang Y; Liu K; Wu J; Gao P; Zhang C
    Front Immunol; 2023; 14():1133297. PubMed ID: 37020547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver fibrosis.
    Bataller R; Brenner DA
    J Clin Invest; 2005 Feb; 115(2):209-18. PubMed ID: 15690074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of Myofibroblasts of Different Origins to Liver Fibrosis.
    Fausther M; Lavoie EG; Dranoff JA
    Curr Pathobiol Rep; 2013 Sep; 1(3):225-230. PubMed ID: 23997993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.